What AngioDynamics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 1 | 1 |
| Total trades | 1 | 41 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 300,522 |
| Disposed | 23,370 | 142,812 |
| Net activity | −23,370 | +157,710 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Nighan Warren Jr | SVP Quality and Regulatory | Jul 30 | Open-market sale · S | −23,370 | $14.72 | −$344K | 64,745 |
| Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 22 | Withheld — tax / exercise cost · F | −2,330 | $13.82 | −$32.2K | 108,676 |
| Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 22 | Exercise / conversion · M | +6,466 | — | — | 111,006 |
| Clemmer James C | President and CEO | Jul 22 | Withheld — tax / exercise cost · F | −26,728 | $13.82 | −$369K | 862,448 |
| Clemmer James C | President and CEO | Jul 22 | Exercise / conversion · M | +52,358 | — | — | 889,176 |
| Trowbridge Stephen A | EVP and CFO | Jul 22 | Withheld — tax / exercise cost · F | −8,319 | $13.82 | −$115K | 305,796 |
| Trowbridge Stephen A | EVP and CFO | Jul 22 | Exercise / conversion · M | +16,296 | — | — | 314,115 |
| Nighan Warren Jr | SVP Quality and Regulatory | Jul 22 | Withheld — tax / exercise cost · F | −1,671 | $13.82 | −$23.1K | 88,115 |
| Nighan Warren Jr | SVP Quality and Regulatory | Jul 22 | Exercise / conversion · M | +5,694 | — | — | 89,786 |
| Piccinini Laura | SVP International | Jul 22 | Withheld — tax / exercise cost · F | −4,506 | $13.82 | −$62.3K | 81,929 |
| Piccinini Laura | SVP International | Jul 22 | Exercise / conversion · M | +8,047 | — | — | 86,435 |
| Trowbridge Stephen A | EVP and CFO | Jul 20 | Withheld — tax / exercise cost · F | −717 | $13.71 | −$9.83K | 244,562 |
| Clemmer James C | President and CEO | Jul 20 | Withheld — tax / exercise cost · F | −4,223 | $13.71 | −$57.9K | 836,818 |
| Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 20 | Withheld — tax / exercise cost · F | −359 | $13.71 | −$4.92K | 88,459 |
| Nighan Warren Jr | SVP Quality and Regulatory | Jul 20 | Withheld — tax / exercise cost · F | −251 | $13.71 | −$3.44K | 66,126 |
| Piccinini Laura | SVP International | Jul 20 | Withheld — tax / exercise cost · F | −616 | $13.71 | −$8.45K | 58,528 |
| Clemmer James C | President and CEO | Jul 19 | Withheld — tax / exercise cost · F | −487 | $13.51 | −$6.58K | 841,041 |
| Clemmer James C | President and CEO | Jul 19 | Withheld — tax / exercise cost · F | −11,764 | $13.51 | −$159K | 841,528 |
| Trowbridge Stephen A | EVP and CFO | Jul 17 | Withheld — tax / exercise cost · F | −3,510 | $13.51 | −$47.4K | 245,279 |
| Clemmer James C | President and CEO | Jul 17 | Withheld — tax / exercise cost · F | −10,649 | $13.51 | −$144K | 853,292 |
Loading...
